Full Professor(heuristic)

Lung Cancer Treatments and Mutations · Pulmonary and Respiratory Medicine

h-index112
i10-index229
Publications667
Citations66,682

Grants

21 total · 0 active

NIH #4P01CA129243-10

Mechanisms and Modulators of Sensitivity and Resistance to EGFR Inhibitors in Lu

Amount
$390K
Period
— → 2018-08-31
PIs
2
Est. capacity / PI
~3 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #2P01CA129243-06

Mechanisms and Modulators of Sensitivity and Resistance to EGFR Inhibitors in Lu

Amount
$399K
Period
2007-07-23 → 2017-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5R01CA121210-07

Overcoming acquired resistance to EGFR inhibitors in lung cancer

Amount
$285K
Period
2007-04-01 → 2017-03-31
PIs
1
Est. capacity / PI
~0 students

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

All Grants

21 total · 0 active

NIH #4P01CA129243-10

Mechanisms and Modulators of Sensitivity and Resistance to EGFR Inhibitors in Lu

Amount
$390K
Period
— → 2018-08-31
PIs
2
Est. capacity / PI
~3 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #2P01CA129243-06

Mechanisms and Modulators of Sensitivity and Resistance to EGFR Inhibitors in Lu

Amount
$399K
Period
2007-07-23 → 2017-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5R01CA121210-07

Overcoming acquired resistance to EGFR inhibitors in lung cancer

Amount
$285K
Period
2007-04-01 → 2017-03-31
PIs
1
Est. capacity / PI
~0 students

NIH #2R01CA121210-06

Overcoming acquired resistance to EGFR inhibitors in lung cancer

Amount
$303K
Period
2007-04-01 → 2017-03-31
PIs
1
Est. capacity / PI
~0 students

NIH #5P01CA129243-09

Mechanisms and Modulators of Sensitivity and Resistance to EGFR Inhibitors in Lu

Amount
$390K
Period
— → 2016-08-31
PIs
2
Est. capacity / PI
~3 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #1P01CA129243-01

EGFR Kinase Inhibitor-Persistent EGFR-Mutant Lung Adenocarcinoma

Amount
$151K
Period
2007-07-01 → 2012-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5R01CA121210-05

Overcoming acquired resistance to EGFR inhibitors in lung cancer

Amount
$258K
Period
2007-04-01 → 2012-02-29
PIs
1
Est. capacity / PI
~0 students

NIH #5R01CA121210-04

Overcoming acquired resistance to EGFR inhibitors in lung cancer

Amount
$265K
Period
2007-04-01 → 2012-02-28
PIs
1
Est. capacity / PI
~0 students

NIH #7R01CA121210-03

Overcoming acquired resistance to EGFR inhibitors in lung cancer

Amount
$264K
Period
2007-04-01 → 2012-02-28
PIs
1
Est. capacity / PI
~0 students

NIH #1R01CA121210-01A1

Overcoming acquired resistance to EGFR inhibitors in lung cancer

Amount
$312K
Period
2007-04-01 → 2012-02-28
PIs
1
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5K08CA097980-04

Elucidating Mechanisms of Lung Tumor Regression

Amount
$102K
Period
2005-09-01 → 2010-08-31
PIs
1
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5K08CA097980-03

Elucidating Mechanisms of Lung Tumor Regression

Amount
$102K
Period
2005-09-01 → 2009-08-31
PIs
1
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5K08CA097980-02

Elucidating Mechanisms of Lung Tumor Regression

Amount
$136K
Period
2005-09-01 → 2009-08-31
PIs
1
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #1K08CA097980-01A2

Elucidating Mechanisms of Lung Tumor Regression

Amount
$136K
Period
2005-09-01 → 2009-08-31
PIs
1
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5R01CA121210-02

Overcoming acquired resistance to EGFR inhibitors in lung cancer

Amount
$312K
Period
2007-04-01 → 2009-02-28
PIs
1
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5P01CA129243-08

Mechanisms and Modulators of Sensitivity and Resistance to EGFR Inhibitors in Lu

Amount
$383K
Period
— → —
PIs
2
Est. capacity / PI
~3 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5P01CA129243-07

Mechanisms and Modulators of Sensitivity and Resistance to EGFR Inhibitors in Lu

Amount
$367K
Period
— → —
PIs
2
Est. capacity / PI
~3 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5P01CA129243-05

EGFR Kinase Inhibitor-Persistent EGFR-Mutant Lung Adenocarcinoma

Amount
$218K
Period
— → —
PIs
1
Est. capacity / PI
~3 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5P01CA129243-04

EGFR Kinase Inhibitor-Persistent EGFR-Mutant Lung Adenocarcinoma

Amount
$225K
Period
— → —
PIs
1
Est. capacity / PI
~3 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5P01CA129243-03

EGFR Kinase Inhibitor-Persistent EGFR-Mutant Lung Adenocarcinoma

Amount
$221K
Period
— → —
PIs
1
Est. capacity / PI
~3 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5P01CA129243-02

EGFR Kinase Inhibitor-Persistent EGFR-Mutant Lung Adenocarcinoma

Amount
$185K
Period
— → —
PIs
1
Est. capacity / PI
~3 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 3 of 3
Open author page on OpenAlex →